Overexpression of CX3CR1 is associated with cellular metastasis, proliferation and survival in gastric cancer

Oncology Reports

Volumn 33, Issue 2, 2015, Pages 615-624

  Wei, Lu Min ^a   Cao, Shan ^a   Yu, Wei Dong ^a   Liu, Yu Lan ^a   Wang, Jing Tong ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

CX3CR1; Gastric cancer

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; PROTEIN KINASE B; CHEMOKINE RECEPTOR; CX3CL1 PROTEIN, HUMAN; CX3CR1 PROTEIN, HUMAN; FRACTALKINE;

ADULT; ARTICLE; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR VOLUME; AGED; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; SURVIVAL; TUMOR CELL LINE; TUMOR INVASION;

AGED; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CX3CL1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTORS, CHEMOKINE; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84919460186     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3645     Document Type: Article

References (42)

1. Brenner H, Rothenbacher D and Arndt V: epidemiology of stomach cancer. Methods Mol Biol 472: 467-477, 2009.
2. Herszenyi L and Tulassay Z: epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 14: 249-258, 2010.
3. Hyung WJ, Noh SH, Yoo CH, et al: Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg 26: 323-329, 2002.
4. Feng J, Wu YF, Xu HM, Wang SB and Chen JQ: Prognostic signifcance of the metastatic lymph node ratio in T3 gastric cancer patients undergoing total gastrectomy. Asian Pac J Cancer Prev 12: 3289-3292, 2011.
5. Zlotnik A and Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127, 2000.
6. Balkwill F: Cancer and the chemokine network. Nat Rev Cancer 4: 540-550, 2004.
7. Zlotnik A: Chemokines in neoplastic progression. Semin Cancer Biol 14: 181-185, 2004.
8. Righi E, Kashiwagi S, Yuan J, et al: CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer. Cancer Res 71: 5522-5534, 2011.
9. Marchesi F, Grizzi F, Laghi L, Mantovani A and Allavena P: Molecular mechanisms of pancreatic cancer dissemination: the role of the chemokine system. Curr Pharm Des 18: 2432-2438, 2012.
10. Balkwill FR: The chemokine system and cancer. J Pathol 226: 148-157, 2012.
11. Yao X, Qi L, Chen X, Du J, Zhang Z and Liu S: expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma. Urol Oncol 32: 162-170, 2014.
12. Wang WN, Chen Y, Zhang YD and Hu TH: The regulatory mechanism of CCR7 gene expression and its involvement in the metastasis and progression of gastric cancer. Tumour Biol 34: 1865-1871, 2013.
13. Marchesi F, Piemonti L, Mantovani A and Allavena P: Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis. Cytokine Growth Factor Rev 21: 77-82, 2010.
14. Lee JH, Cho YS, Lee JY, et al: The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer. Ann Surg 249: 933-941, 2009.
15. Jamieson WL, Shimizu S, D'ambrosio JA, Meucci O and Fatatis A: CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism. Cancer Res 68: 1715-1722, 2008.
16. Marchesi F, Piemonti L, Fedele G, et al: The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma. Cancer Res 68: 9060-9069, 2008.
17. Kodama J, Hasengaowa, Kusumoto T, et al: Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer. Ann Oncol 18: 70-76, 2007.
18. Miao Z, Luker KE, Summers BC, et al: CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 104: 15735-15740, 2007.
19. Andre F, Cabioglu N, Assi H, et al: Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer. Ann Oncol 17: 945-951, 2006.
20. Meijer J, Zeelenberg IS, Sipos B and Roos E: The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver. Cancer Res 66: 9576-9582, 2006.
21. Shulby SA, Dolloff NG, Stearns ME, Meucci O and Fatatis A: CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Res 64: 4693-4698, 2004.
22. Marchesi F, Monti P, Leone BE, et al: Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 64: 8420-8427, 2004.
23. Mashino K, Sadanaga N, Yamaguchi H, et al: Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 62: 2937-2941, 2002.
24. Brand S, Sakaguchi T, Gu X, Colgan SP and Reinecker HC: Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology 122: 166-177, 2002.
25. Muller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
26. White GE and Greaves DR: Fractalkine: one chemokine, many functions. Blood 113: 767-768, 2009.
27. Bazan JF, Bacon KB, Hardiman G, et al: A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640-644, 1997.
28. Lucas AD, Chadwick N, Warren BF, et al: The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am J Pathol 158: 855-866, 2001.
29. Hundhausen C, Misztela D, Berkhout TA, et al: The disintegrin-like metalloproteinase aDaM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102: 1186-1195, 2003.
30. Imai T, Hieshima K, Haskell C, et al: Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91: 521-530, 1997.
31. Nevo I, Sagi-Assif O, Meshel T, et al: The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells. Cancer Lett 273: 127-139, 2009.
32. Locatelli M, Boiocchi L, Ferrero S, et al: Human glioma tumors express high levels of the chemokine receptor CX3CR1. Eur Cytokine Netw 21: 27-33, 2010.
33. Zhao BC, Wang ZJ, Mao WZ, et al: CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. World J Gastroenterol 17: 2389-2396, 2011.
34. Meucci O, Fatatis A, Simen AA and Miller RJ: Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA 97: 8075-8080, 2000.
35. Alessi DR, Andjelkovic M, Caudwell B, et al: Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541-6551, 1996.
36. Gaudin F, Nasreddine S, Donnadieu AC, et al: identifcation of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer. PLoS One 6: e21546, 2011.
37. Lee SJ, Namkoong S, Kim YM, et al: Fractalkine stimulates angioGenesis by activating the Raf-1/MEK/ERK-and PI3K/akt/enoS-dependent signal pathways. am J Physiol Heart Circ Physiol 291: H2836-H2846, 2006.
38. Ishigami S, Natsugoe S, Okumura H, et al: Clinical implication of CXCL12 expression in gastric cancer. Ann Surg Oncol 14: 3154-3158, 2007.
39. Murdoch C, Monk PN and Finn A: Functional expression of chemokine receptor CXCR4 on human epithelial cells. Immunology 98: 36-41, 1999.
40. Banas B, Wornle M, Berger T, et al: Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J Immunol 168: 4301-4307, 2002.
41. Schutyser E, Su Y, Yu Y, et al: Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells. Eur Cytokine Netw 18: 59-70, 2007.
42. Ishikawa T, Nakashiro K, Klosek SK, et al: Hypoxia enhances CXCR4 expression by activating HiF-1 in oral squamous cell carcinoma. Oncol Rep 21: 707-712, 2009.